| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/24/2013 | US8613719 Dosage sensing unit with tactile feedback |
| 12/24/2013 | CA2759060C A drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic |
| 12/24/2013 | CA2721485C Ordered mesoporous silica material |
| 12/24/2013 | CA2661561C Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water |
| 12/24/2013 | CA2644035C Process for producing a solid dispersion of an active ingredient |
| 12/24/2013 | CA2625875C Encapsulation system |
| 12/24/2013 | CA2608505C Colonic delivery of adsorbents |
| 12/24/2013 | CA2583756C Pharmaceutical composition comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 12/24/2013 | CA2557369C Liquid, peg-free, cold-processable oil-in-water emulsifiers obtainable by combining emulsifiers based on polyol partial esters and acid partial esters |
| 12/24/2013 | CA2516107C A method for production of emulsion-based microparticles |
| 12/24/2013 | CA2500822C Nodulisporic acid derivative spot-on formulations for combating parasites |
| 12/22/2013 | CA2817910A1 Compound for treating hypocalcaemia in ruminants |
| 12/19/2013 | WO2013188847A1 Compositions and methods for transmucosal absorption |
| 12/19/2013 | WO2013188819A2 Mucoadhesive devices for delivery of active agents |
| 12/19/2013 | WO2013188786A1 Compositions and methods for treating airway inflammatory diseases |
| 12/19/2013 | WO2013188737A2 Methods for improved delivery of aminothiols, dimers of aminothiols, and heterodimers composed of aminothiols |
| 12/19/2013 | WO2013188681A1 Polymeric treatment compositions |
| 12/19/2013 | WO2013188586A1 Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan |
| 12/19/2013 | WO2013188497A2 A smart, self-decontaminating polymer and method for inhibiting the growth of a bacteria and fungus |
| 12/19/2013 | WO2013188483A1 Effervescent dosage form |
| 12/19/2013 | WO2013188314A1 Compounds for treating inflammation and pain |
| 12/19/2013 | WO2013188283A1 Topical ophthalmological pharmaceutical composition containing sunitinib |
| 12/19/2013 | WO2013188279A1 Topical ophthalmological pharmaceutical composition containing cediranib |
| 12/19/2013 | WO2013188273A1 Topical ophthalmological pharmaceutical composition containing axitinib |
| 12/19/2013 | WO2013188268A1 Topical ophthalmological pharmaceutical composition containing pazopanib |
| 12/19/2013 | WO2013188217A1 Therapeutic formulation and methods of treatment |
| 12/19/2013 | WO2013188214A1 Compounds for treating inflammation and pain |
| 12/19/2013 | WO2013188212A1 Sustained release hydrogle-based stimulant |
| 12/19/2013 | WO2013187984A1 Compositions and methods for enhancing the efficacy of contraceptive microbicides |
| 12/19/2013 | WO2013187980A1 Nanoceria for the treatment of oxidative stress |
| 12/19/2013 | WO2013187853A1 Encapsulated protein-containing product (variants) |
| 12/19/2013 | WO2013187852A1 Encapsulated protein-containing product and method for producing same |
| 12/19/2013 | WO2013187720A1 Novel composition for the treatment of gastroesophageal reflux disease |
| 12/19/2013 | WO2013187700A1 Pharmaceutical combined formulation comprising metformin and hmg-coa reductase inhibitor |
| 12/19/2013 | WO2013187626A1 Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same |
| 12/19/2013 | WO2013187451A1 Patch |
| 12/19/2013 | WO2013187395A1 Tablet having ingestion easiness and dividability |
| 12/19/2013 | WO2013187283A1 Material for testing eating and deglutition function |
| 12/19/2013 | WO2013187088A1 Method for producing powder for inhalation |
| 12/19/2013 | WO2013187075A1 Prophylactic and/or therapeutic agent for mild cognitive impairment |
| 12/19/2013 | WO2013186793A1 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells |
| 12/19/2013 | WO2013186746A1 Desethylamiodarone compositions |
| 12/19/2013 | WO2013186700A1 Antibody formulation |
| 12/19/2013 | WO2013186390A1 Selective crystallization processes using reverse micelle and w/o microemulsion systems - multitask emulsion crystallization (mec) |
| 12/19/2013 | WO2013186370A1 Oral pharmaceutical formulation of bcs class iii molecules |
| 12/19/2013 | WO2013186355A1 A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota |
| 12/19/2013 | WO2013186320A1 Pharmaceutical composition comprising crystalline posaconazole |
| 12/19/2013 | WO2013186311A1 Extended release formulations |
| 12/19/2013 | WO2013186292A2 Method for obtaining a nano-capsule structure |
| 12/19/2013 | WO2013186286A1 Tailored liposomes for the treatment of bacterial infections |
| 12/19/2013 | WO2013186230A1 Pharmaceutical formulation for a therapeutic antibody |
| 12/19/2013 | WO2013186191A1 Formulations of metronidazole for the treatment of pouchitis |
| 12/19/2013 | WO2013185934A1 Method of preparing a composition based on hyaluronic acid |
| 12/19/2013 | WO2013185789A1 Pharmaceutical composition containing phosphate binding polymer |
| 12/19/2013 | WO2013185505A1 Olanzapine oral instant membrane |
| 12/19/2013 | WO2013185294A1 Chinese medicine for preventing and treating rhagades and frostbite and preparation method thereof |
| 12/19/2013 | WO2013185178A1 Nanoemulsions |
| 12/19/2013 | WO2013144176A9 Controlled release formulation comprising mesalamine |
| 12/19/2013 | WO2013127539A3 Pharmaceutical formulation containing flupirtin |
| 12/19/2013 | WO2013114053A3 Extended-release pharmaceutical composition of trimetazidine |
| 12/19/2013 | WO2003057278A3 Drug delivery system for sustained delivery of glipizide |
| 12/19/2013 | US20130338645 Transdermal drug delivery method and system |
| 12/19/2013 | US20130338574 Oral medicinal composition for patients undergoing peritoneal dialysis and method for using same |
| 12/19/2013 | US20130338569 Polymeric hydrogel compositions which release active agents in response to electrical stimulus |
| 12/19/2013 | US20130338242 Cloud mixer and method of minimizing agglomeration of particulates |
| 12/19/2013 | US20130338238 Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation |
| 12/19/2013 | US20130338230 Dermatological foams obtained from a gel or suspension containing adapalene |
| 12/19/2013 | US20130338206 Topical liquid to ameliorate pain and promote healing of burn-injured skin |
| 12/19/2013 | US20130338180 Formulation comprising phenylaminopyrimidine derivative as active agent |
| 12/19/2013 | US20130338122 Transdermal hormone replacement therapies |
| 12/19/2013 | US20130338121 Two speed monolithic system for controlled release of drugs |
| 12/19/2013 | US20130338083 Methods of providing therapeutic effects using cyclosporin components |
| 12/19/2013 | US20130338082 Methods of providing therapeutic effects using cyclosporin components |
| 12/19/2013 | US20130338071 GLP-1 Agonist and Cardiovascular Complications |
| 12/19/2013 | US20130337148 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 12/19/2013 | US20130337096 Chewable vehicle for mouth absorption |
| 12/19/2013 | US20130337077 Nanospheres for therapeutic agent delivery |
| 12/19/2013 | US20130337076 Particles containing a growth factor, and uses thereof |
| 12/19/2013 | US20130337074 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis |
| 12/19/2013 | US20130337073 Controlled release particles |
| 12/19/2013 | US20130337072 Controlled release particles and production method thereof |
| 12/19/2013 | US20130337071 Radiofrequency-induced synchronization of in situ hyperthermia and chemotherapy via magnetic-nanoconjugates |
| 12/19/2013 | US20130337070 Coated Nanoparticle Therapy for Skin Cancer |
| 12/19/2013 | US20130337068 Carotenoid particles and uses thereof |
| 12/19/2013 | US20130337067 Non-viral nanoparticle-based delivery system |
| 12/19/2013 | US20130337066 Membrane Encapsulated Nanoparticles and Method of Use |
| 12/19/2013 | US20130337065 Aptamer bioconjugate drug delivery device |
| 12/19/2013 | US20130337063 Pharmaceutical compositions of maraviroc and process for the preparation thereof |
| 12/19/2013 | US20130337062 Gastro-resistant enzyme pharmaceutical compositions |
| 12/19/2013 | US20130337061 Pharmaceutical compositions for sleep apnea |
| 12/19/2013 | US20130337060 Oral Pharmaceutical Dosage Forms |
| 12/19/2013 | US20130337059 Oral Pharmaceutical Dosage Forms |
| 12/19/2013 | US20130337058 Micronized Tanaproget and Compositions Containing Same |
| 12/19/2013 | US20130337056 Coated solid pharmaceutical preparation |
| 12/19/2013 | US20130337053 Novel formulations and methods |
| 12/19/2013 | US20130337052 System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication |
| 12/19/2013 | US20130337051 Advanced active liposomal loading of poorly water-soluble substances |
| 12/19/2013 | US20130337047 Compositions for treating oral and periodontal infections |
| 12/19/2013 | US20130337045 Controlled activation of complement components for use as endogenous adjuvant |
| 12/19/2013 | US20130337044 Modulation of effector t cell responses by local depletion of complement component c3 |